🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Baseline SGLT2 inhibitor use and documented ascites after a first ascites hospitalization: a retrospective two-center cohort study.

Article C Peer reviewed Observational

Key takeaways

This study looked at people with liver disease and diabetes who were hospitalized for fluid buildup. It found that taking a certain diabetes drug, called an SGLT2 inhibitor, was linked to less fluid buildup during follow-up. This shows a link, not proof of cause, but it may help manage fluid in these patients.

Who did this work

Riado Mínguez D · Parra Villanueva FJ · Rodríguez Heinsen AC · Fernández-Gordón Sánchez FMª · Agudo Fernández S · Cuadrado Tiemblo C · Bejerano Domínguez A · Castaño Milla C

Source

Article · PubMed, the drug frontier · 2026 Nov 12
https://pubmed.ncbi.nlm.nih.gov/43018354/